hotspot -WSS

hotspot

author：focus 2025-09-06 04:14:15 - browse：738

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： As obesity drug market grows, telehealth companies court payers

WSS

Intellia plays down concerns on accidental germline transmission

Investment in vaccine development is lagging, report finds

Listen: Vivek Ramaswamy's star turn & leaky drug data

Boston competes with Raleigh

FDA advisory panel to debate high blood pressure devices

Wegovy improves function in certain heart failure patients

focus

hotspot

Wikipedia

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Sports medicine is finally prioritizing gender equality

New clues to why women have higher risk of autoimmune disorders

Dobbs anniversary: the lost opportunity of abortion as health care

California store owner shot dead in dispute over displaying Pride flag: Police

The high cost of giving birth even with insurance

DeSantis wants to import drugs. Biden’s FDA blasted his plan

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Intellia plays down concerns on accidental germline transmission

hotspot

Abortion policy in the spotlight at Republican debate

Venture capital firm's plans to take over Akron hospital face hurdles

Investment in vaccine development is lagging, report finds

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Humana’s losses in Medicare Advantage tank its stock

Hospital at home shows how to bring innovation to health care

focus

leisure time

hotspot

leisure time